» Articles » PMID: 33046261

MRI Characteristics of MOG-Ab Associated Disease in Adults: An Update

Overview
Specialty Neurology
Date 2020 Oct 13
PMID 33046261
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Our knowledge of the radiological spectrum of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is growing rapidly. An update on the radiological features of the disease, and its evolution is thus necessary. Magnetic resonance imaging (MRI) has an increasingly important role in the differential diagnosis of MOGAD particularly from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and multiple sclerosis (MS). Differentiating these conditions is of prime importance because the management is different between the three inflammatory diseases, and thus could prevent further attack-related disability. Therefore, identifying the MRI features suggestive of MOGAD has diagnostic and prognostic implications. We herein review optic nerve, spinal cord and the brain MRI findings from MOGAD adult patients, and compare them to AQP4-NMOSD and MS.

Citing Articles

Clinical, Demographic, and Radiological Characteristics of Patients Demonstrating Antibodies Against Myelin Oligodendrocyte Glycoprotein.

Koc S, Sen S, Terzi Y, Kizilay F, Demir S, Bekar Aksoy D Balkan Med J. 2024; 41(4):272-279.

PMID: 38828767 PMC: 11588904. DOI: 10.4274/balkanmedj.galenos.2024.2024-1-97.


AQP4-IgG NMOSD, MOGAD, and double-seronegative NMOSD: is it possible to depict the antibody subtype using magnetic resonance imaging?.

Fragoso D, Salles L, Apostolos Pereira S, Callegaro D, Sato D, de Medeiros Rimkus C Arq Neuropsiquiatr. 2023; 81(6):533-543.

PMID: 37379865 PMC: 10306980. DOI: 10.1055/s-0043-1768669.


Comparison of MRI T2-lesion evolution in pediatric MOGAD, NMOSD, and MS.

Redenbaugh V, Chia N, Cacciaguerra L, Mccombe J, Tillema J, Chen J Mult Scler. 2023; 29(7):799-808.

PMID: 37218499 PMC: 10626581. DOI: 10.1177/13524585231166834.


Current Updates on the Diagnosis and Management of Multiple Sclerosis for the General Neurologist.

Baskaran A, Grebenciucova E, Shoemaker T, Graham E J Clin Neurol. 2023; 19(3):217-229.

PMID: 37151139 PMC: 10169923. DOI: 10.3988/jcn.2022.0208.


Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis.

Jarius S, Aktas O, Ayzenberg I, Bellmann-Strobl J, Berthele A, Giglhuber K J Neurol. 2023; 270(7):3341-3368.

PMID: 37022481 PMC: 10267280. DOI: 10.1007/s00415-023-11634-0.